432 related articles for article (PubMed ID: 17001705)
21. Cytomegalovirus and human herpesvirus 8 DNA detection in peripheral blood monocytic cells of AIDS patients: correlations with the presence of Kaposi's sarcoma and CMV disease.
van der Kuyl AC; Polstra AM; van den Burg R; Jan Weverling G; Goudsmit J; Cornelissen M
J Med Virol; 2005 Aug; 76(4):541-6. PubMed ID: 15977227
[TBL] [Abstract][Full Text] [Related]
22. The role of human herpesvirus 8 in the pathogenesis of Kaposi's sarcoma.
Blauvelt A
Adv Dermatol; 1999; 14():167-206; discussion 207. PubMed ID: 10643499
[TBL] [Abstract][Full Text] [Related]
23. KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.
Ma T; Patel H; Babapoor-Farrokhran S; Franklin R; Semenza GL; Sodhi A; Montaner S
Angiogenesis; 2015 Oct; 18(4):477-88. PubMed ID: 26092770
[TBL] [Abstract][Full Text] [Related]
24. The pleiotropic effects of Kaposi's sarcoma herpesvirus.
Schulz TF
J Pathol; 2006 Jan; 208(2):187-98. PubMed ID: 16362980
[TBL] [Abstract][Full Text] [Related]
25. [Update on Kaposi's sarcoma].
Morand JJ; Lightburn E; Simon F; Patte JH
Med Trop (Mars); 2007 Apr; 67(2):123-30. PubMed ID: 17691428
[TBL] [Abstract][Full Text] [Related]
26. Investigational agents for treatment of AIDS-related Kaposi's sarcoma.
Konstantinopoulos PA; Sullivan RJ; Karamouzis MV; Dezube BJ
Expert Opin Investig Drugs; 2007 Apr; 16(4):495-504. PubMed ID: 17371197
[TBL] [Abstract][Full Text] [Related]
27. KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma.
Liu W; Lacouture ME; Jiang J; Kraus M; Dickstein J; Soltani K; Shea CR
J Cutan Pathol; 2006 Sep; 33 Suppl 2():46-51. PubMed ID: 16972955
[TBL] [Abstract][Full Text] [Related]
28. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
[TBL] [Abstract][Full Text] [Related]
29. Cultured AIDS-related Kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: implication for oxidant stress in AIDS-KS pathogenesis.
Mallery SR; Bailer RT; Hohl CM; Ng-Bautista CL; Ness GM; Livingston BE; Hout BL; Stephens RE; Brierley GP
J Cell Biochem; 1995 Nov; 59(3):317-28. PubMed ID: 8567750
[TBL] [Abstract][Full Text] [Related]
30. Anthrax lethal toxin inhibits growth of and vascular endothelial growth factor release from endothelial cells expressing the human herpes virus 8 viral G protein coupled receptor.
Depeille P; Young JJ; Boguslawski EA; Berghuis BD; Kort EJ; Resau JH; Frankel AE; Duesbery NS
Clin Cancer Res; 2007 Oct; 13(19):5926-34. PubMed ID: 17908989
[TBL] [Abstract][Full Text] [Related]
31. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
Dezube BJ
Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
[TBL] [Abstract][Full Text] [Related]
32. Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor.
Geras-Raaka E; Varma A; Clark-Lewis I; Gershengorn MC
Biochem Biophys Res Commun; 1998 Dec; 253(3):725-7. PubMed ID: 9918794
[TBL] [Abstract][Full Text] [Related]
33. The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma.
Jensen KK; Manfra DJ; Grisotto MG; Martin AP; Vassileva G; Kelley K; Schwartz TW; Lira SA
J Immunol; 2005 Mar; 174(6):3686-94. PubMed ID: 15749907
[TBL] [Abstract][Full Text] [Related]
34. Kaposi sarcoma.
Radu O; Pantanowitz L
Arch Pathol Lab Med; 2013 Feb; 137(2):289-94. PubMed ID: 23368874
[TBL] [Abstract][Full Text] [Related]
35. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.
Sirianni MC; Vincenzi L; Topino S; Giovannetti A; Mazzetta F; Libi F; Scaramuzzi D; Andreoni M; Pinter E; Baccarini S; Rezza G; Monini P; Ensoli B
Eur J Immunol; 2002 Oct; 32(10):2711-20. PubMed ID: 12355422
[TBL] [Abstract][Full Text] [Related]
36. Kaposi's sarcoma. An Update.
Zalla MJ
Dermatol Surg; 1996 Mar; 22(3):274-87. PubMed ID: 8599740
[TBL] [Abstract][Full Text] [Related]
37. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis.
Polstra AM; Cornelissen M; Goudsmit J; van der Kuyl AC
J Med Virol; 2004 Nov; 74(3):390-6. PubMed ID: 15368522
[TBL] [Abstract][Full Text] [Related]
38. Molecular epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 strains from Russian patients with classic, posttransplant, and AIDS-associated Kaposi's sarcoma.
Kadyrova E; Lacoste V; Duprez R; Pozharissky K; Molochkov V; Huerre M; Gurtsevitch V; Gessain A
J Med Virol; 2003 Dec; 71(4):548-56. PubMed ID: 14556268
[TBL] [Abstract][Full Text] [Related]
39. Expression of interleukin-6 receptors and NF-kappa B in AIDS-related Kaposi sarcoma cell strains.
Bailer RT; Ng-Bautista CL; Ness GM; Mallery SR
Lymphology; 1997 Jun; 30(2):63-76. PubMed ID: 9215976
[TBL] [Abstract][Full Text] [Related]
40. Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma.
Engels EA; Rosenberg PS; Frisch M; Goedert JJ
Br J Cancer; 2001 Nov; 85(9):1298-303. PubMed ID: 11720464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
